Alex Herrera, MD
Researcher Spotlight: Alex Herrera, MD Beckman Research Institute at the City of Hope Dr. Herrera’s project for the Lymphoma Clinical Research Mentoring Program (LCRMP) tests a combination of pembrolizumab (Keytruda) and vorinostat (Zolinza), a histone deacetylase inhibitor (HDAC), in…